UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A review of the role of surgery for small cell lung cancer and the potential prognostic value of enumeration of circulating tumor cells

European journal of surgical oncology, 2016-09, Vol.42 (9), p.1296-1302

2016

Volltextzugriff (PDF)

6P CHEMOTHERAPY-ENFORCED EXPRESSION OF CANCER STEM CELL MARKERS IN A SERIES OF THREE SCLC CELL LINES OBTAINED DURING CLINICAL TREATMENT

Lung cancer (Amsterdam, Netherlands), 2013-05, Vol.80, p.S3-S3

2013

Volltextzugriff (PDF)

The impact of extracellular matrix on the chemoresistance of solid tumors – experimental and clinical results of hyaluronidase as additive to cytostatic chemotherapy

Cancer letters, 1998-09, Vol.131 (1), p.85-99

1998

Volltextzugriff (PDF)

Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer

The New England journal of medicine, 2012-02, Vol.366 (7), p.601-609

2012

Volltextzugriff (PDF)

Evidence for the conversion of docetaxel into 7'-epidocetaxel in patients receiving Taxotere-based conventional chemotherapy

International journal of clinical pharmacology and therapeutics, 2010-07, Vol.48 (7), p.483-484

2010

Volltextzugriff (PDF)

Expression of Proteolytic Enzymes by Small Cell Lung Cancer Circulating Tumor Cell Lines

Cancers, 2019-01, Vol.11 (1), p.114

2019

Volltextzugriff (PDF)

Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: A phase III trial

Lung cancer (Amsterdam, Netherlands), 2006-05, Vol.52 (2), p.155-163

2006

Volltextzugriff (PDF)

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial

The lancet oncology, 2013-02, Vol.14 (2), p.125-133

2013

Volltextzugriff (PDF)

1110 Significance of the neurotensin – Na+/H+-exchanger axis for the metastatic potential of pancreatic carcinoma cell lines

European journal of cancer supplements, 2009, Vol.7 (2), p.117-118

2009

Volltextzugriff (PDF)

Achieving full-dose, on-schedule administration of ACE chemotherapy every 14 days for the treatment of patients with extensive small-cell lung cancer

Lung, 2006-10, Vol.184 (5), p.279-285

2006

Volltextzugriff (PDF)

1083 In vitro comparison of the platinum (IV) drugs oxoplatin and satraplatin

European journal of cancer supplements, 2009, Vol.7 (2), p.110-110

2009

Volltextzugriff (PDF)

Osseous metastases in breast cancer: radiographic monitoring of therapeutic response

Anticancer research, 2002-03, Vol.22 (2B), p.1279

2002

Volltextzugriff (PDF)

Docetaxel Therapie im fortgeschrittenen nicht-kleinzelligen Bronchialkarzinom (NSCLC) - Resultate einer Observationsstudie mit Fokus auf Verbesserung von Tumor-assoziierten Symptomen unter Therapie

Pneumologie (Stuttgart, Germany), 2013, Vol.67 (5)

2013

Volltextzugriff (PDF)

Testing for anti-p53 antibodies increases the diagnostic sensitivity of conventional tumor markers

International journal of oncology, 2006-10, Vol.29 (4), p.973-980

2006

Volltextzugriff (PDF)

Expression profiling reveals different targeted genes of the oral platinum(IV) prodrug oxoplatin and its putative activation product cisplatin

European journal of cancer supplements, 2008, Vol.6 (9), p.31-31

2008

Volltextzugriff (PDF)

Prolonged response to a single androgen suppression phase in a subpopulation of prostate cancer patients

Annals of oncology, 2000-07, Vol.11 (7), p.877-881

2000

Volltextzugriff (PDF)

Resveratrol pretreatment desensitizes AHTO-7 human osteoblasts to growth stimulation in response to carcinoma cell supernatants

International journal of oncology, 1999-11, Vol.15 (5), p.955

1999

Volltextzugriff (PDF)

Randomized phase II study of three doses of the integrin inhibitor cilengitide versus docetaxel as second-line treatment for patients (pts) with stage IV non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.8014-8014

2009

Volltextzugriff (PDF)

Comparison of the effects of the oral anticancer platinum(IV) complexes oxoplatin and metabolite cis-diammine-tetrachlorido-platinum(IV) on global gene expression of NCI-H526 cells

Journal of experimental pharmacology, 2011-04, Vol.3 (default), p.43-50

2011

Volltextzugriff (PDF)

Antitumor effects of new proline analogs on cancer cell lines in vitro

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3164-3164

2004

Volltextzugriff (PDF)

A phase II study of pegfilgrastim to support ACE 14 chemotherapy for the treatment of subjects with small cell lung cancer (SCLC; extensive disease)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.7216-7216

2004

Volltextzugriff (PDF)

A phase II study of pegfilgrastim to support ACE 14 chemotherapy for the treatment of subjects with small cell lung cancer (SCLC; extensive disease)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.7216-7216

2004

Volltextzugriff (PDF)

Antitumor effects of new proline analogs on cancer cell lines in vitro

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3164-3164

2004

Volltextzugriff (PDF)

Multimodality treatment for small cell bronchial carcinoma : preliminary results of a prospective, multicenter trial

European journal of cardio-thoracic surgery, 1991, Vol.5 (6), p.306-310

1991

Volltextzugriff (PDF)

1 – 25 von 112

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(94)

Publikationsform

Sprache

Englisch
(88)
Deutsch
(29)

Erscheinungsjahr

n.n

Thema

Humans
(27)
Science & Technology
(24)
Life Sciences & Biomedicine
(22)
Female
(16)
Middle Aged
(15)
Oncology
(15)
Biological And Medical Sciences
(14)
Male
(14)
Medical Sciences
(14)
Aged
(13)
Adult
(12)
Hematology, Oncology And Palliative Medicine
(7)
Lung Neoplasms - Pathology
(7)
Neoplasm Staging
(7)
Treatment Outcome
(7)
Antineoplastic Agents
(6)
Chemotherapy
(6)
Lung Neoplasms - Drug Therapy
(6)
Pharmacology. Drug Treatments
(6)
Metastasis
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A review of the role of surgery for small cell lung cancer and the potential prognostic value of enumeration of circulating tumor cells

6P CHEMOTHERAPY-ENFORCED EXPRESSION OF CANCER STEM CELL MARKERS IN A SERIES OF THREE SCLC CELL LINES OBTAINED DURING CLINICAL TREATMENT

The impact of extracellular matrix on the chemoresistance of solid tumors – experimental and clinical results of hyaluronidase as additive to cytostatic chemotherapy

Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer

Evidence for the conversion of docetaxel into 7'-epidocetaxel in patients receiving Taxotere-based conventional chemotherapy

Expression of Proteolytic Enzymes by Small Cell Lung Cancer Circulating Tumor Cell Lines

Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: A phase III trial

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial

1110 Significance of the neurotensin – Na+/H+-exchanger axis for the metastatic potential of pancreatic carcinoma cell lines

Achieving full-dose, on-schedule administration of ACE chemotherapy every 14 days for the treatment of patients with extensive small-cell lung cancer

1083 In vitro comparison of the platinum (IV) drugs oxoplatin and satraplatin

Osseous metastases in breast cancer: radiographic monitoring of therapeutic response

Docetaxel Therapie im fortgeschrittenen nicht-kleinzelligen Bronchialkarzinom (NSCLC) - Resultate einer Observationsstudie mit Fokus auf Verbesserung von Tumor-assoziierten Symptomen unter Therapie

Testing for anti-p53 antibodies increases the diagnostic sensitivity of conventional tumor markers

Expression profiling reveals different targeted genes of the oral platinum(IV) prodrug oxoplatin and its putative activation product cisplatin

Prolonged response to a single androgen suppression phase in a subpopulation of prostate cancer patients

Resveratrol pretreatment desensitizes AHTO-7 human osteoblasts to growth stimulation in response to carcinoma cell supernatants

PS1331 MYELOMONOCYTIC SKEWING IN CHRONIC MYELOMONOCYTIC LEUKEMIA: PHENOTYPIC, GENOTYPIC AND BIOLOGIC FEATURES AND IMPACT ON SURVIVAL

Randomized phase II study of three doses of the integrin inhibitor cilengitide versus docetaxel as second-line treatment for patients (pts) with stage IV non-small cell lung cancer (NSCLC)

Comparison of the effects of the oral anticancer platinum(IV) complexes oxoplatin and metabolite cis-diammine-tetrachlorido-platinum(IV) on global gene expression of NCI-H526 cells

Antitumor effects of new proline analogs on cancer cell lines in vitro

A phase II study of pegfilgrastim to support ACE 14 chemotherapy for the treatment of subjects with small cell lung cancer (SCLC; extensive disease)

A phase II study of pegfilgrastim to support ACE 14 chemotherapy for the treatment of subjects with small cell lung cancer (SCLC; extensive disease)

Antitumor effects of new proline analogs on cancer cell lines in vitro

Multimodality treatment for small cell bronchial carcinoma : preliminary results of a prospective, multicenter trial

Suchergebnisse filtern